Skip to content

Study on device to identify blocked breathing in patients during sleep

Dozee as a Screening Tool for Sleep Apnea Detection Classification and Sleep Staging - NIL

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068760
Enrollment
500
Registered
2024-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 4- Measurement and Monitoring

Interventions

Intervention1: DOZEE: Ballistocardiography based non invasive device. Each patient in the sleep lab will be subject simulatenous recording along with the comparator wihc will last approximately 5-9 h

Sponsors

Turtle Shell Technologies Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults of age 18 to 80 years Able to provide written informed consent Weight above 40 to 120Kgs

Exclusion criteria

Exclusion criteria: Weight below 40 kgs and above 120 kgs. A likely need to receive or undergo a procedure/care during the testing period Have a pacemaker or defibrillator A significant medical condition in the judgment of the investigator which may compromise the study testing procedures

Design outcomes

Primary

MeasureTime frame
Sensitivity of Dozee in detection of sleep apnea in comparison with the gold standard PSGTimepoint: At Baseline during patient enrolment in the study

Secondary

MeasureTime frame
Dozee classification of apnea severity according to standard AASM classification Dozee sensitivity in the classification of apnea according to standard AASM classification Dozee sensitivity in identifying all apneic events observed in the PSG Correlation between Dozee AHI values and PSG AHI Dozee Sleep stage classification and its correlation with sleep stages from PSG study Motion detection of Dozee compared to gross movement manual detection in the PSG study Snoring detection of Dozee compared to the snoring detection in the PSG study Hypoxic episodes detection by Dozee pulse oximeterTimepoint: At Baseline during patient enrolment in the study

Countries

India

Contacts

Public ContactDr Kumar Chokalingam

Turtle Shell Technologies Pvt Ltd

kumar.chokalingam@dozee.io908349922

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026